Association of Adjuvant or Metastatic Setting With Discontinuation of Cancer Drugs in Clinical Trials
Sign Up to like & getrecommendations! Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.12327
Abstract: Key Points Question How does the percentage of patients who withdraw from adjuvant trials because of adverse events compare with patients who withdraw from metastatic trials for the same drug? Findings In this cross-sectional study,… read more here.
Keywords: setting discontinuation; adjuvant metastatic; metastatic setting; cancer drugs ... See more keywords
Chemoradiotherapy Versus Chemotherapy Alone for Advanced Esophageal Squamous Cell Carcinoma: The Role of Definitive Radiotherapy for Primary Tumor in the Metastatic Setting
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.824206
Abstract: Introduction The role of definitive radiotherapy in advanced esophageal squamous cell carcinoma (ESCC), especially in the metastatic setting, remains unclear. Therefore, we aimed to investigate the efficacy of chemoradiotherapy (CRT) versus chemotherapy (CT) alone in… read more here.
Keywords: role definitive; definitive radiotherapy; metastatic setting; radiotherapy ... See more keywords